Description

3,4-Dihydro-8-Amino-6-Methylthio-2H-Pyrimido[4,5-E]-1,2,4-Thiadiazine 1,1-Dioxide is a high-purity, heterocyclic organic compound with a complex fused-ring structure, serving as a critical advanced pharmaceutical intermediate. Its value lies in its role as a sophisticated building block for the synthesis of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring targeted molecular design. This product is essential for research institutions and pharmaceutical manufacturers engaged in the development of new drugs, where precise chemical architecture is paramount for biological activity.

Application

• Pharmaceutical Intermediate: A key precursor in the synthesis of novel drug candidates, particularly for central nervous system (CNS) or anti-infective applications.
• Research & Development: Used in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization processes.
• Active Pharmaceutical Ingredient (API) Synthesis: Incorporated into the final chemical structure of proprietary pharmaceutical compounds.
• Biochemical Research: Potential use as a tool compound for studying specific enzymatic or receptor interactions in vitro.
• Fine Chemical Production: Serves as a specialized intermediate for other high-value, complex organic molecules.

Basic Information

Product Name	3,4-Dihydro-8-Amino-6-Methylthio-2H-Pyrimido[4,5-E]-1,2,4-Thiadiazine 1,1-Dioxide
CAS No.	74051-77-7
Molecular Formula	C7H8N6O2S2
Molecular Weight	272.31 g/mol
Synonyms	8-Amino-6-(methylthio)-3,4-dihydro-2H-pyrimido[4,5-e][1,2,4]thiadiazine 1,1-dioxide; 6-Methylthio-8-amino-3,4-dihydro-2H-pyrimido[4,5-e]-1,2,4-thiadiazine 1,1-dioxide; CAS 74051-77-7; 8-Amino-6-methylsulfanyl-3,4-dihydro-2H-pyrimido[4,5-e][1,2,4]thiadiazine 1,1-dioxide; 2H-Pyrimido[4,5-e]-1,2,4-thiadiazine, 3,4-dihydro-8-amino-6-(methylthio)-, 1,1-dioxide
EINECS	Contact for details

Quality Control

Our 3,4-Dihydro-8-Amino-6-Methylthio-2H-Pyrimido[4,5-E]-1,2,4-Thiadiazine 1,1-Dioxide is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical R&D and production. Certificates of Analysis (COA) detailing all specifications are provided and can be tailored to meet specific client requirements.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at controlled room temperature (typically 15-25°C). Keep away from incompatible materials. For long-term storage, consider conditions under an inert atmosphere to ensure stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 98.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.